Stock Track | Tempus AI Soars 6.21% Intraday on Mizuho's Bullish Initiation and New AI Algorithm Announcement

Stock Track

17 hours ago

Tempus AI's stock experienced a significant surge of 6.21% during intraday trading on Thursday. The healthcare-focused artificial intelligence company saw heightened investor activity following positive developments.

The upward movement appears to be driven primarily by Mizuho Securities initiating coverage of Tempus AI with an Outperform rating and a $100 price target. Analyst Bradley Bowers' bullish outlook has generated increased investor interest in the company's stock.

Additionally, the company recently announced a new HRD-RNA algorithm, an AI-driven tool designed to enhance the detection of homologous recombination deficiency in tumors. This algorithm analyzes gene expression to identify patients who could benefit from platinum-based chemotherapy or PARP inhibitors, with clinical availability planned for later this year.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1195532844"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1195532844\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1195532844?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-20 03:29","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1195532844","market":"us","top_or_hot":-1,"title":"Stock Track | Tempus AI Soars 6.21% Intraday on Mizuho's Bullish Initiation and New AI Algorithm Announcement","media":"Stock Track","content":"<p>Tempus AI's stock experienced a significant surge of 6.21% during intraday trading on Thursday. The healthcare-focused artificial intelligence company saw heightened investor activity following positive developments.</p><p>The upward movement appears to be driven primarily by Mizuho Securities initiating coverage of Tempus AI with an Outperform rating and a $100 price target. Analyst Bradley Bowers' bullish outlook has generated increased investor interest in the company's stock.</p><p>Additionally, the company recently announced a new HRD-RNA algorithm, an AI-driven tool designed to enhance the detection of homologous recombination deficiency in tumors. This algorithm analyzes gene expression to identify patients who could benefit from platinum-based chemotherapy or PARP inhibitors, with clinical availability planned for later this year.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Tempus AI Soars 6.21% Intraday on Mizuho's Bullish Initiation and New AI Algorithm Announcement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Tempus AI Soars 6.21% Intraday on Mizuho's Bullish Initiation and New AI Algorithm Announcement\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-20 03:29</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Tempus AI's stock experienced a significant surge of 6.21% during intraday trading on Thursday. The healthcare-focused artificial intelligence company saw heightened investor activity following positive developments.</p><p>The upward movement appears to be driven primarily by Mizuho Securities initiating coverage of Tempus AI with an Outperform rating and a $100 price target. Analyst Bradley Bowers' bullish outlook has generated increased investor interest in the company's stock.</p><p>Additionally, the company recently announced a new HRD-RNA algorithm, an AI-driven tool designed to enhance the detection of homologous recombination deficiency in tumors. This algorithm analyzes gene expression to identify patients who could benefit from platinum-based chemotherapy or PARP inhibitors, with clinical availability planned for later this year.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TEM","symbol_name":"Tempus AI","start_time":0,"source_url":"","article_id":"1195532844","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1195532844","pubTimestamp":1771529356,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Tempus AI's stock experienced a significant surge of 6.21% during intraday trading on Thursday. The healthcare-focused artificial intelligence company saw heightened investor activity following...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TEM":"Tempus AI"},"translate_title":"股票赛道|瑞穗看涨启动和新AI算法公布腾邦AI盘中大涨6.21%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TEM":1},"content_text":"Tempus AI's stock experienced a significant surge of 6.21% during intraday trading on Thursday. The healthcare-focused artificial intelligence company saw heightened investor activity following positive developments.The upward movement appears to be driven primarily by Mizuho Securities initiating coverage of Tempus AI with an Outperform rating and a $100 price target. Analyst Bradley Bowers' bullish outlook has generated increased investor interest in the company's stock.Additionally, the company recently announced a new HRD-RNA algorithm, an AI-driven tool designed to enhance the detection of homologous recombination deficiency in tumors. This algorithm analyzes gene expression to identify patients who could benefit from platinum-based chemotherapy or PARP inhibitors, with clinical availability planned for later this year.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}